查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1628892

下一代糖尿病治療和藥物傳輸市場，按產品類型、適應症、人口統計、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Next Generation Diabetes Therapy and Drug Delivery Market, By Product Type, By Indication, By Demographic, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，下一代糖尿病治療和藥物輸送市場規模為98.2032億美元，2024年至2032年複合年成長率為14.29%。

下一代糖尿病治療與藥物傳輸市場-市場動態

糖尿病盛行率不斷上升推動市場需求

全球糖尿病盛行率不斷上升，推動了對創新療法的需求。此外，城市化、不健康飲食和體力活動減少正在促進下一代糖尿病治療和藥物傳輸市場的成長。然而，高成本和監管挑戰可能會阻礙市場成長。相反，開發負擔得起的、低副作用的產品和大量未確診的糖尿病患者為市場提供了巨大的成長機會。此外，連續血糖監測 (CGM) 和胰島素貼片的發展正在改善糖尿病管理，使治療更有效、更侵入性。

下一代糖尿病治療和藥物傳輸市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 14.29% 左右的複合年成長率成長

根據產品類型細分，預計 CGM 系統將在 2023 年顯示最大的市場佔有率

根據適應症細分，第2型糖尿病是2023年的主導細分市場

根據人口細分，2023年成年人口（>14歲）是主導群體

按地區分類，北美是 2023 年的主要收入來源

下一代糖尿病治療和藥物輸送市場細分分析：

全球新一代糖尿病治療和藥物傳輸市場根據產品類型、適應症、人口統計、最終用戶和地區進行細分。

根據產品類型，市場分為五類：口服胰島素、吸入性胰島素、CGM系統、胰島素貼片和人工胰臟。 CGM 系統領域主導著市場。這可以歸因於這些系統相對於傳統糖尿病產品的優勢，包括方便用戶使用的功能以及更快、更有效地檢測血糖水平變化的能力。

根據適應症，市場分為兩類：1 型糖尿病和第 2 型糖尿病。 2 型糖尿病領域在市場上佔據主導地位，並可能在預測期內保持其主導地位。部分原因是城市化進程加快、不良飲食和久坐的生活方式導致第 2 型糖尿病盛行率增加。

下一代糖尿病治療和藥物傳輸市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

下一代糖尿病治療與藥物輸送市場-競爭格局：

由於對更有效、侵入性更小的糖尿病管理的需求不斷成長，各公司正在專注於創新解決方案，例如口服和吸入胰島素、胰島素貼片和連續血糖監測系統。製造商擴大投資於研發，以創造非侵入性、方便用戶使用的產品。策略夥伴關係、與科技公司的合作以及對專業新創公司的收購正在幫助公司增強其產品組合併加速下一代療法的商業化。

最新進展：

2024 年 6 月，阿斯特捷利康的 Farxiga（達格列淨）獲得批准，用於改善 10 歲及以上 2 型糖尿病兒科患者的血糖控制。此次批准是在 T2NOW III 期試驗取得積極結果之後進行的，標誌著兒科糖尿病治療取得了重大進展。 Farxiga 先前已被批准用於治療第 2 型糖尿病成人患者。

目錄

第 1 章：下一代糖尿病治療與藥物傳遞市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的下一代糖尿病治療和藥物傳輸市場片段
    • 下一代糖尿病治療和藥物傳輸市場片段（按適應症）
    • 按人口統計的下一代糖尿病治療和藥物傳輸市場片段
    • 最終用戶的下一代糖尿病治療和藥物傳輸市場片段
    • 按國家/地區分類的下一代糖尿病治療和藥物傳輸市場片段
    • 按地區分類的下一代糖尿病治療和藥物傳輸市場片段
  • 競爭洞察

第 3 章：下一代糖尿病和藥物傳輸主要市場趨勢

  • 下一代糖尿病治療和藥物傳輸市場促進因素
    • 市場促進因素的影響分析
  • 下一代糖尿病治療和藥物傳輸市場限制
    • 市場限制影響分析
  • 下一代糖尿病治療與藥物輸送市場機會
  • 下一代糖尿病治療和藥物傳輸市場的未來趨勢

第 4 章：下一代糖尿病與藥物輸送產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：下一代糖尿病治療與藥物輸送市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章：下一代糖尿病治療與藥物輸送市場格局

  • 2023 年下一代糖尿病治療和藥物傳遞市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：下一代糖尿病治療和藥物傳輸市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 口服胰島素
    • 吸入型胰島素
    • 連續GM系統
    • 胰島素貼片
    • 人工胰臟

第 8 章：下一代糖尿病治療和藥物傳輸市場 - 按適應症

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 1 型糖尿病
    • 2 型糖尿病

第 9 章：下一代糖尿病治療和藥物傳輸市場 - 按人口統計

  • 概述
    • 按人口統計分類的細分市場佔有率分析
    • 兒童人口（14 歲）
    • 成人人口（>14 歲）

第 10 章：下一代糖尿病治療和藥物輸送市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 家庭醫療保健
    • 重症加護病房
    • 診斷/診所

第 11 章：下一代糖尿病治療和藥物傳輸市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美下一代糖尿病和藥物傳輸主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按指標）
    • 北美市場規模和預測（按人口統計）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲下一代糖尿病和藥物傳輸主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按指標）
    • 歐洲市場規模和預測（按人口統計）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區下一代糖尿病和藥物傳輸主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模與預測（依人口統計）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲下一代糖尿病和藥物傳輸主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按指標）
    • 拉丁美洲市場規模與預測（按人口統計）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲下一代糖尿病和藥物傳輸主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模及預測（按人口統計）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 下一代糖尿病和藥物輸送產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • MannKind Corporation
    • Medtronic plc
    • Dexcom, Inc.
    • Novo Nordisk A/S
    • Senseonics Holdings, Inc.
    • Eli Lilly and Company
    • Abbott laboratories
    • Glysens Incorporated
    • Johnson & Johnson
    • Sanofi SA
    • Enteris BioPharma
    • Echo Therapeutics, Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4421

REPORT HIGHLIGHT

Next generation diabetes therapy and drug delivery market size was valued at USD 9,820.32 Million in 2023, expanding at a CAGR of 14.29% from 2024 to 2032.

Next-generation diabetes therapy and drug delivery aim to improve the management of blood glucose levels through advanced, less invasive methods. These include oral and inhalable insulin, insulin patches, continuous glucose monitoring (CGM) systems, and artificial pancreas technologies. By reducing the need for needles, these innovations minimize pain and skin irritation, offering patients more convenient, effective, and comfortable solutions for managing their diabetes and adjusting insulin levels based on real-time glucose data.

Next Generation Diabetes Therapy and Drug Delivery Market- Market Dynamics

Growing prevalence of diabetes to propel market demand

The rising global prevalence of diabetes is driving demand for innovative therapies. Besides, urbanization, unhealthy diets, and reduced physical activity are contributing to the growth of the next-generation diabetes therapy and drug delivery market. However, high costs and regulatory challenges may hamper the market growth. On the contrary, development of affordable, low-side-effect products and the large population of undiagnosed diabetic patients present significant growth opportunities for the market. Furthermore, developments in continuous glucose monitoring (CGM) and insulin patches are improving diabetes management, making treatments more efficient and less invasive.

Next Generation Diabetes Therapy and Drug Delivery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.29% over the forecast period (2024-2032)

Based on product type segmentation, CGM systems was predicted to show maximum market share in the year 2023

Based on indication segmentation, Type 2 diabetes was the leading segment in 2023

Based on demographic segmentation, adult population (>14 years) was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Next Generation Diabetes Therapy and Drug Delivery Market- Segmentation Analysis:

The Global Next Generation Diabetes Therapy and Drug Delivery Market is segmented on the basis of Product Type, Indication, Demographic, End User, and Region.

The market is divided into five categories based on product type: oral insulin, inhalable insulin, CGM systems, insulin patches, and artificial pancreas. The CGM systems sector dominates the market. This can be attributed to the benefits of these systems over traditional diabetes products, including user-friendly features and the ability to detect changes in blood glucose levels more quickly and efficiently.

The market is divided into two categories based on indication: Type 1 diabetes and Type 2 diabetes. The type 2 diabetes sector dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the prevalence of type 2 diabetes owing to by increasing urbanization, poor diets, and sedentary lifestyles.

Next Generation Diabetes Therapy and Drug Delivery Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Next Generation Diabetes Therapy and Drug Delivery Market- Competitive Landscape:

Driven by the growing demand for more effective and less invasive diabetes management, companies are focusing on innovative solutions such as oral and inhalable insulin, insulin patches, and continuous glucose monitoring systems. Manufacturers are increasingly investing in research and development to create non-invasive, user-friendly products. Strategic partnerships, collaborations with tech firms, and acquisitions of specialized startups are helping companies enhance their product portfolios and accelerate the commercialization of next-generation therapies.

Recent Developments:

In June 2024, AstraZeneca received approval for its Farxiga (dapagliflozin) for improving glycaemic control in pediatric patients aged 10 and older with type-2 diabetes. This approval follows positive results from the T2NOW Phase III trial, marking a significant development in pediatric diabetes treatment. Farxiga was previously approved for adults with type-2 diabetes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • MannKind Corporation
  • Medtronic plc
  • Dexcom, Inc.
  • Novo Nordisk A/S
  • Senseonics Holdings, Inc.
  • Eli Lilly and Company
  • Abbott laboratories
  • Glysens Incorporated
  • Johnson & Johnson
  • Sanofi S.A.
  • Enteris BioPharma
  • Echo Therapeutics, Inc.
  • Others

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Oral Insulin
  • Inhalable Insulin
  • CGM Systems
  • Insulin Patches
  • Artificial Pancreas

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Type 1 Diabetes
  • Type 2 Diabetes

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY DEMOGRAPHIC- MARKET ANALYSIS, 2019 - 2032

  • Child Population (14 years)
  • Adult Population (<14 years)

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Home Healthcare
  • ICUs
  • Diagnostic/Clinics

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Next Generation Diabetes Therapy and Drug Delivery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Product Type
    • 2.1.2. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Indication
    • 2.1.3. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Demographic
    • 2.1.4. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by End User
    • 2.1.5. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Country
    • 2.1.6. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Region
  • 2.2. Competitive Insights

3. Next Generation Diabetes and Drug Delivery Key Market Trends

  • 3.1. Next Generation Diabetes Therapy and Drug Delivery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Next Generation Diabetes Therapy and Drug Delivery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Next Generation Diabetes Therapy and Drug Delivery Market Opportunities
  • 3.4. Next Generation Diabetes Therapy and Drug Delivery Market Future Trends

4. Next Generation Diabetes and Drug Delivery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Next Generation Diabetes Therapy and Drug Delivery Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Next Generation Diabetes Therapy and Drug Delivery Market Landscape

  • 6.1. Next Generation Diabetes Therapy and Drug Delivery Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Next Generation Diabetes Therapy and Drug Delivery Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Oral Insulin
    • 7.1.3. Inhalable Insulin
    • 7.1.4. CGM Systems
    • 7.1.5. Insulin Patches
    • 7.1.6. Artificial Pancreas

8. Next Generation Diabetes Therapy and Drug Delivery Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Type 1 Diabetes
    • 8.1.3. Type 2 Diabetes

9. Next Generation Diabetes Therapy and Drug Delivery Market - By Demographic

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Demographic, 2023 & 2032 (%)
    • 9.1.2. Child Population (14 years)
    • 9.1.3. Adult Population (>14 years)

10. Next Generation Diabetes Therapy and Drug Delivery Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2. Home Healthcare
    • 10.1.3. ICUs
    • 10.1.4. Diagnostic/Clinics

11. Next Generation Diabetes Therapy and Drug Delivery Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Next Generation Diabetes and Drug Delivery Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. MannKind Corporation
    • 12.2.2. Medtronic plc
    • 12.2.3. Dexcom, Inc.
    • 12.2.4. Novo Nordisk A/S
    • 12.2.5. Senseonics Holdings, Inc.
    • 12.2.6. Eli Lilly and Company
    • 12.2.7. Abbott laboratories
    • 12.2.8. Glysens Incorporated
    • 12.2.9. Johnson & Johnson
    • 12.2.10. Sanofi S.A.
    • 12.2.11. Enteris BioPharma
    • 12.2.12. Echo Therapeutics, Inc.
    • 12.2.13. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us